A disintegrin and metalloproteinase with thrombospondin motifs 4 is an enzyme that in humans is encoded by the ADAMTS4gene.[1]
This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The enzyme encoded by this gene lacks a C-terminal TS motif. It can degrade aggrecan, a major proteoglycan of cartilage, brevican, a brain-specific extracellular matrix protein, neurocan and versican. The cleavage of aggrecan and brevican suggests key roles of this enzyme in arthritic disease and in the central nervous system, potentially, in the progression of glioma.[2]
ADAMTS4 is the shortest known ADAMTS, lacking the C-terminal domain and is the only non-glycosylated ADAMTS.[3] It also only has one thrombospondin type 1 motif (TSR), whereas all the other ADAMTS have two or more TSRs. The TSR is important for binding of the enzyme to the extracellular matrix and hence its substrate specificity. Adjacent to the C-terminal TSR is a disintegrin-like domain, a cysteine-rich region
that stacks against the active-site of the enzyme when in its final folded tertiary structure.[4]
Aggrecanase-1 (initial name reflecting its ability to cleave aggrecan)
References
↑Tang BL, Hong W (Feb 1999). "ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats". FEBS Letters. 445 (2–3): 223–5. doi:10.1016/S0014-5793(99)00119-2. PMID10094461.
↑Wayne GJ, Deng SJ, Amour A, Borman S, Matico R, Carter HL, Murphy G (2007). "TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4". J. Biol. Chem. 282 (29): 20991–8. doi:10.1074/jbc.M610721200. PMID17470431.
↑Takizawa M, Yatabe T, Okada A, Chijiiwa M, Mochizuki S, Ghosh P, Okada Y (2008). "Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes". FEBS Lett. 582 (19): 2945–9. doi:10.1016/j.febslet.2008.07.036. PMID18671975.
↑Bondeson J, Wainwright S, Hughes C, Caterson B (2008). "The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review". Clin. Exp. Rheumatol. 26 (1): 139–45. PMID18328163.
Further reading
Tang BL (Jan 2001). "ADAMTS: a novel family of extracellular matrix proteases". The International Journal of Biochemistry & Cell Biology. 33 (1): 33–44. doi:10.1016/S1357-2725(00)00061-3. PMID11167130.
Hirohata S (Nov 2001). "[ADAMTS family--new extracellular matrix degrading enzyme]". Seikagaku. The Journal of Japanese Biochemical Society. 73 (11): 1333–7. PMID11831030.
Ishikawa K, Nagase T, Suyama M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O (Jun 1998). "Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro". DNA Research. 5 (3): 169–76. doi:10.1093/dnares/5.3.169. PMID9734811.
Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R, Rockwell A, Yang F, Duke JL, Solomon K, George H, Bruckner R, Nagase H, Itoh Y, Ellis DM, Ross H, Wiswall BH, Murphy K, Hillman MC, Hollis GF, Newton RC, Magolda RL, Trzaskos JM, Arner EC (Jun 1999). "Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins". Science. 284 (5420): 1664–6. doi:10.1126/science.284.5420.1664. PMID10356395.
Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, Ellis DM, Tortorella MD, Pratta MA, Hollis JM, Wynn R, Duke JL, George HJ, Hillman MC, Murphy K, Wiswall BH, Copeland RA, Decicco CP, Bruckner R, Nagase H, Itoh Y, Newton RC, Magolda RL, Trzaskos JM, Burn TC (Aug 1999). "Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family". The Journal of Biological Chemistry. 274 (33): 23443–50. doi:10.1074/jbc.274.33.23443. PMID10438522.
Hurskainen TL, Hirohata S, Seldin MF, Apte SS (Sep 1999). "ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family". The Journal of Biological Chemistry. 274 (36): 25555–63. doi:10.1074/jbc.274.36.25555. PMID10464288.
Tortorella MD, Pratta M, Liu RQ, Austin J, Ross OH, Abbaszade I, Burn T, Arner E (Jun 2000). "Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4)". The Journal of Biological Chemistry. 275 (24): 18566–73. doi:10.1074/jbc.M909383199. PMID10751421.
Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K, Arner EC, Hockfield S (Jul 2000). "Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member". The Journal of Biological Chemistry. 275 (30): 22695–703. doi:10.1074/jbc.M909764199. PMID10801887.
Tortorella M, Pratta M, Liu RQ, Abbaszade I, Ross H, Burn T, Arner E (Aug 2000). "The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage". The Journal of Biological Chemistry. 275 (33): 25791–7. doi:10.1074/jbc.M001065200. PMID10827174.
Nakamura H, Fujii Y, Inoki I, Sugimoto K, Tanzawa K, Matsuki H, Miura R, Yamaguchi Y, Okada Y (Dec 2000). "Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites". The Journal of Biological Chemistry. 275 (49): 38885–90. doi:10.1074/jbc.M003875200. PMID10986281.
Mizui Y, Yamazaki K, Kuboi Y, Sagane K, Tanaka I (Sep 2000). "Characterization of 5'-flanking region of human aggrecanase-1 (ADAMTS4) gene". Molecular Biology Reports. 27 (3): 167–73. doi:10.1023/A:1007253930568. PMID11254106.
Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN, Clowes AW (Apr 2001). "Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4". The Journal of Biological Chemistry. 276 (16): 13372–8. doi:10.1074/jbc.M009737200. PMID11278559.
Gao G, Westling J, Thompson VP, Howell TD, Gottschall PE, Sandy JD (Mar 2002). "Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation". The Journal of Biological Chemistry. 277 (13): 11034–41. doi:10.1074/jbc.M107443200. PMID11796708.
Yamanishi Y, Boyle DL, Clark M, Maki RA, Tortorella MD, Arner EC, Firestein GS (Feb 2002). "Expression and regulation of aggrecanase in arthritis: the role of TGF-beta". Journal of Immunology. 168 (3): 1405–12. doi:10.4049/jimmunol.168.3.1405. PMID11801682.
Westling J, Fosang AJ, Last K, Thompson VP, Tomkinson KN, Hebert T, McDonagh T, Collins-Racie LA, LaVallie ER, Morris EA, Sandy JD (May 2002). "ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain". The Journal of Biological Chemistry. 277 (18): 16059–66. doi:10.1074/jbc.M108607200. PMID11854269.
Malfait AM, Liu RQ, Ijiri K, Komiya S, Tortorella MD (Jun 2002). "Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage". The Journal of Biological Chemistry. 277 (25): 22201–8. doi:10.1074/jbc.M200431200. PMID11956193.
External links
The MEROPS online database for peptidases and their inhibitors: M12.221